Prognostic impact of proteolytic factors (uPA, PAI-1, cathepsins B, D, L) in primary breast cancer reflects effects of adjuvant systemic therapy - Harbeck, N; Alt, U; Krüger, A (Clin Cancer Res, 2001)
et al.